We didn’t set out to build a stent. We set out to solve a moment no one forgets.

pa·ten·cy

The condition of being open, expanded, or unobstructed.

Peytant was founded by medtech veterans with a mission to give clinicians tools they can trust in the toughest scenarios.

Our proprietary use of human amnion, a form of placental tissue, powers a new generation of amnion-derived membrane coverings that help reduce the body’s natural foreign body response, often associated with implants used to treat luminal disease.

Our Mission

To fundamentally transform the treatment of all luminal diseases by increasing patency.

Executive Team

John Schorgl

FOUNDER, CHAIR, CEO, & PRESIDENT
Schneider (Pfizer), Boston Scientific, Baxter Int, SuperDimension, Coulter
F. Edwin Froelich MD, JD

MEDICAL DIRECTOR
Vanderbilt School Med, Georgetown Law
Elizabeth Burnett

VP MARKETING
Medtronic, St. Jude Medical, Miromatrix, Vomaris
Lou Ellis

VP QUALITY, REGULATORY & PROJECT MANAGEMENT
Boston Scientific, Greatbatch (Integer), Smiths Medical
Stacey Bremer

DIRECTOR OF REGULATORY AFFAIRS & QUALITY ASSURANCE
Boston Scientific, NAMSA, Abbott
Brian Brown

VP R&D
Cogentix, OvaGene, Boston Scientific
Dale Brady

DIRECTOR OF OPERATIONS
Endogenix, Osprey Medical, Anulex

Board of Directors

John Schorgl

FOUNDER, CHAIR, CEO, & PRESIDENT
Schneider (Pfizer), Boston Scientific, Baxter Int, SuperDimension, Coulter
Clay Anselmo

DIRECTOR
Former President & CEO, Reglera (acquired Dohmen Life)
Bruce Faulken

DIRECTOR
Faulken Law
Steve Healy

FOUNDER & DIRECTOR
St. Jude Medical, Schneider (Pfizer), Zimmer Spine, Disc Dynamics, ActivOrtho
Craig Walker MD

CHIEF MEDICAL OFFICER
Harvard Brigham & Women's, Cardiovascular Institute South